Literature DB >> 34324120

Functional neurological disorder after COVID-19 vaccination.

Tommaso Ercoli1, Laura Lutzoni2, Gianni Orofino2, Antonella Muroni2, Giovanni Defazio3,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34324120      PMCID: PMC8319586          DOI: 10.1007/s10072-021-05504-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
Dear Editor, Functional neurological disorder (FND) is characterized by symptoms such as paralysis, sensory disturbances, and seizures that can be identified as related to alterations in functioning of brain networks rather than disorders of brain structures. The diagnosis of FND is based on the demonstration of incongruence with a known clinical pattern and/or inconsistency over time and may be supported by the presence of positive signs (e.g., Hoover’s sign in functional leg weakness) [1]. Psychological stressors such as stressful life events, physical trauma (e.g., infections and adverse drug reaction), and medical comorbidities (e.g., other neurological diseases and pain) have been associated with the development of FND [2, 3]. As the COVID-19 vaccination program is currently ongoing worldwide and some videos circulated on social media about neurological adverse events following administration of the vaccine, a JAMA Neurology Viewpoint and a press release from the FND Society (https://www.fndsociety.org/UserFiles/file/FNDSSocietyPressReleaseCOVIDVaccines.pdf) discussed the possibility of FND developing after vaccination and reassured public opinion about the safety of the COVID-19 vaccine [4]. Although FND can be sometimes diagnosed from videos with good accuracy, we here report the first description of FND after the COVID-19 vaccine as evaluated by a team of neurologists. In the middle of February 2021, a 41-year-old man received the first jab of vaccine against COVID-19. Two episodes of anaphylactic shock were the only remarkable events in his past medical history. After a few minutes from the injection, he reported bilateral facial paralysis with difficulty to blink and move the facial muscles properly. Within 40 min, all the symptoms resolved spontaneously. Three weeks later, a few minutes after the second jab, he complained of swollen tongue and respiratory impairment, which was quickly resolved by corticosteroid therapy. In the meantime, he developed right-sided weakness, at the same side of the injection, lasting for about 40 min. A couple of weeks later, he suddenly manifested left-sided facial hypoesthesia, and due to the persistency of symptom, he was admitted to our ward. Neurological examination revealed midline splitting of sensory deficit in the face with tacto-dolorific hypoesthesia. Neurological examination was otherwise unrevealing. Head CT and brain MRI were normal, as well as carotid artery Doppler ultrasonography. Two weeks later, sensory disturbance resolved, and the neurological examination was normal. To our knowledge, this is the first full description of a FND case associated to COVID-19 vaccine. We assessed at the bedside only the sensory loss with a clear edge on the facial midline, which is a sign with a good positive predictive value for FND, especially when thalamic lesions have been excluded [5]. We did not evaluate the other symptoms reported immediately after the jabs, but their features and course seemed to confirm the FND diagnosis. Indeed, acute and serious neurological adverse event after vaccine is thankfully rare, and bilateral facial palsy and transient weakness are likely to be transient ischemic attack mimics. Overall, the patients suffered from a variety of neurological symptoms in the last two months, confirming inconsistency over time. Current hypothesis highlights the importance of attention and beliefs/expectation in the pathophysiology and phenomenology of FND [6]. Abnormal expectations about illness may be generated by a range of predisposing factors related to beliefs on and personal experience of illness. These may include physical illness in the patient him- or herself, exposure to illness in the family [7] or while in a medical or paramedical job, health scares in the media or within colleagues, or myriad other sociocultural means. Abnormal beliefs about illness may also be a source of increased attention towards symptoms. It is notable that a physical precipitating event is commonly reported close to the onset of FND [2], which may also provide an explanation as to why particular FND develops. In our patient, the stressful conditions associated to the pandemic [8], together with other predisposing factors, might have contributed to both increased attention towards body signals and abnormal expectations/belief about symptoms, while the content of the abnormal prior expectation might have arisen from vaccination-linked injury [4]. This case highlights the need to prompt diagnose FND in order to avoid misleading and dangerous opinion related to neurological side effects of the vaccines. It’s important to recognize FND symptoms and to reassure public opinion that these are not neuro-toxic effects of the vaccine.
  8 in total

Review 1.  The role of physical injury in motor and sensory conversion symptoms: a systematic and narrative review.

Authors:  Jon Stone; Alan Carson; Hosakere Aditya; Robin Prescott; Mohammad Zaubi; Charles Warlow; Michael Sharpe
Journal:  J Psychosom Res       Date:  2008-12-17       Impact factor: 3.006

2.  Disease modeling in functional movement disorders.

Authors:  Roberta Pellicciari; Maria Superbo; Angelo Fabio Gigante; Paolo Livrea; Giovanni Defazio
Journal:  Parkinsonism Relat Disord       Date:  2014-09-16       Impact factor: 4.891

3.  Helping the Public Understand Adverse Events Associated With COVID-19 Vaccinations: Lessons Learned From Functional Neurological Disorder.

Authors:  David Dongkyung Kim; Candice S Kung; David L Perez
Journal:  JAMA Neurol       Date:  2021-04-09       Impact factor: 18.302

Review 4.  Functional sensory symptoms.

Authors:  J Stone; M Vermeulen
Journal:  Handb Clin Neurol       Date:  2016

5.  Functional motor disorders associated with other neurological diseases: Beyond the boundaries of "organic" neurology.

Authors:  Michele Tinazzi; Christian Geroin; Roberto Erro; Enrico Marcuzzo; Sofia Cuoco; Roberto Ceravolo; Sonia Mazzucchi; Andrea Pilotto; Alessandro Padovani; Luigi Michele Romito; Roberto Eleopra; Mario Zappia; Alessandra Nicoletti; Carlo Dallocchio; Carla Arbasino; Francesco Bono; Angelo Pascarella; Benedetta Demartini; Orsola Gambini; Nicola Modugno; Enrica Olivola; Laura Bonanni; Elena Antelmi; Elisabetta Zanolin; Alberto Albanese; Gina Ferrazzano; Rosa de Micco; Leonardo Lopiano; Giovanna Calandra-Buonaura; Martina Petracca; Marcello Esposito; Antonio Pisani; Paolo Manganotti; Fabrizio Stocchi; Mario Coletti Moja; Angelo Antonini; Tommaso Ercoli; Francesca Morgante
Journal:  Eur J Neurol       Date:  2021-01-02       Impact factor: 6.089

6.  A Bayesian account of 'hysteria'.

Authors:  Mark J Edwards; Rick A Adams; Harriet Brown; Isabel Pareés; Karl J Friston
Journal:  Brain       Date:  2012-05-28       Impact factor: 13.501

Review 7.  Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders.

Authors:  Alberto J Espay; Selma Aybek; Alan Carson; Mark J Edwards; Laura H Goldstein; Mark Hallett; Kathrin LaFaver; W Curt LaFrance; Anthony E Lang; Tim Nicholson; Glenn Nielsen; Markus Reuber; Valerie Voon; Jon Stone; Francesca Morgante
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

8.  A longitudinal study on the mental health of general population during the COVID-19 epidemic in China.

Authors:  Cuiyan Wang; Riyu Pan; Xiaoyang Wan; Yilin Tan; Linkang Xu; Roger S McIntyre; Faith N Choo; Bach Tran; Roger Ho; Vijay K Sharma; Cyrus Ho
Journal:  Brain Behav Immun       Date:  2020-04-13       Impact factor: 7.217

  8 in total
  11 in total

1.  The association between urinary pentosidine levels and cognition in drug-naïve patients with Parkinson's disease.

Authors:  Shusaku Omoto; Mitsuru Saito; Hidetomo Murakami; Tomotaka Shiraishi; Tomomichi Kitagawa; Takeo Sato; Hiroki Takatsu; Teppei Komatsu; Kenichiro Sakai; Tadashi Umehara; Hidetaka Mitsumura; Yasuyuki Iguchi
Journal:  Neurol Sci       Date:  2022-08-12       Impact factor: 3.830

Review 2.  Does Olfactory Dysfunction Correlate with Disease Progression in Parkinson's Disease? A Systematic Review of the Current Literature.

Authors:  Tommaso Ercoli; Carla Masala; Gianluca Cadeddu; Marcello Mario Mascia; Gianni Orofino; Angelo Fabio Gigante; Paolo Solla; Giovanni Defazio; Lorenzo Rocchi
Journal:  Brain Sci       Date:  2022-04-19

3.  Inactivated COVID-19 vaccine induced acute stroke-like focal neurologic symptoms: a case series.

Authors:  Duangnapa Roongpiboonsopit; Chichaya Nithisathienchai; Wasan Akarathanawat; Krittanon Lertutsahakul; Jarturon Tantivattana; Anand Viswanathan; Nijasri Charnnarong Suwanwela
Journal:  BMC Neurol       Date:  2022-06-07       Impact factor: 2.903

Review 4.  Psychiatric adverse reactions to COVID-19 vaccines: A rapid review of published case reports.

Authors:  Ilambaridhi Balasubramanian; Abdul Faheem; Susanta Kumar Padhy; Vikas Menon
Journal:  Asian J Psychiatr       Date:  2022-04-13

5.  [Functional neurological disorders in post COVID-19 patients. Case series].

Authors:  S Albu; Z Guven; M Vallés; H Kumru
Journal:  Neurologia       Date:  2022-02-03       Impact factor: 3.109

6. 

Authors:  Sergio Nuñez Sevillano
Journal:  Rev Psiquiatr Salud Ment       Date:  2022-03-21       Impact factor: 6.795

Review 7.  Neurological side effects of SARS-CoV-2 vaccinations.

Authors:  Josef Finsterer
Journal:  Acta Neurol Scand       Date:  2021-11-08       Impact factor: 3.209

8.  Patients with post-COVID-19 vaccination facial palsy: To boost or not to boost?

Authors:  Nicola Cirillo; Massimiliano Orlandi; Giuseppe Colella
Journal:  Transl Neurosci       Date:  2022-08-22       Impact factor: 1.264

9.  Functional neurological disorders: an Australian interdisciplinary perspective.

Authors:  Elizabeth Pepper; Adith Mohan; Kenneth Butcher; Mark Parsons; Jackie Curtis
Journal:  Med J Aust       Date:  2022-05-14       Impact factor: 12.776

10.  Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders?

Authors:  Tommaso Ercoli; Michele Tinazzi; Christian Geroin; Enrico Marcuzzo; Roberto Erro; Sofia Cuoco; Roberto Ceravolo; Sonia Mazzucchi; Andrea Pilotto; Alessandro Padovani; Luigi Michele Romito; Roberto Eleopra; Mario Zappia; Alessandra Nicoletti; Carlo Dallocchio; Carla Arbasino; Francesco Bono; Giorgio Spano; Benedetta Demartini; Orsola Gambini; Nicola Modugno; Enrica Olivola; Laura Bonanni; Alberto Albanese; Gina Ferrazzano; Alessandro Tessitore; Leonardo Lopiano; Giovanna Calandra-Buonaura; Martina Petracca; Francesca Morgante; Marcello Esposito; Antonio Pisani; Paolo Manganotti; Lucia Tesolin; Francesco Teatini; Fabrizio Stocchi; Giovanni Defazio
Journal:  J Neural Transm (Vienna)       Date:  2022-08-16       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.